Engineered High-Affinity Human T Cell Receptors - EP3071594A1

Sat, 18 Apr 2026 03:29:10 +0000
Intellectual Property

The European Patent Office published patent application EP3071594A1 for engineered high-affinity human T cell receptors, filed by the Board of Trustees of the University of Illinois. The invention relates to engineered high-affinity human T cell receptors (TCRs) with applications in cancer immunotherapy. The application is classified under C07K 14/725, A61K 38/17, and A61P 35/00, with designation extending to all EU member states plus other European countries.